| Identification | Back Directory | [Name]
Disodium 7,7'-(carbonyldiimino)bis(4-hydroxynaphthalene-2-sulphonate) | [CAS]
20324-87-2 | [Synonyms]
AMI-1;AMI 1;AMI1
AMI-1 disodium salt
AMI-1 - AMI-1 sodium salt
J acid urea,disodiuM salt 70%
Disodium 6,6'-ureylenebis[1-naphthol-3-sulfonate]
Sodium 6,6'-(1,3-ureylene) bis(1-naphthol-3-sulfonate)
SODIUM 6,6'-(1,3-UREYLENE) BIS(1,1'-NAPHTHOL)-3,3'-SULFONATE
Disodium 7,7'-(carbonyldiimino)bis(4-hydroxynaphthalene-2-sulphonate)
7,7'-(carbonyldiimino)bis(4-hydroxy-2-naphthalenesulfonic acid) disodium salt
4-hydroxy-7-[(5-hydroxy-7-sulfonatonaphthalen-2-yl)carbamoylamino]naphthalene-2-sulfonate
disodium 4-hydroxy-7-[(5-hydroxy-7-sulfonato-2-naphthyl)carbamoylamino]naphthalene-2-sulfonate
disodium 4-hydroxy-7-[(5-hydroxy-7-sulfonatonaphthalen-2-yl)carbamoylamino]naphthalene-2-sulfonate
disodium 4-hydroxy-7-[(5-hydroxy-7-sulfonato-naphthalen-2-yl)carbamoylamino]naphthalene-2-sulfonate | [EINECS(EC#)]
243-735-4 | [Molecular Formula]
C21H14N2Na2O9S2 | [MDL Number]
MFCD00068249 | [MOL File]
20324-87-2.mol | [Molecular Weight]
548.45 |
| Hazard Information | Back Directory | [Chemical Properties]
Light grey paste. Soluble in water and easily soluble in alkaline solution. | [Uses]
AMI-1 is a Histone Methyltransferase (HMT) inhibitor. | [Biological Activity]
potent, cell permeable and specific protein arginine n-methyltransferase 1 (prmt1) inhibitor (ic50 = 8, 8 μm), does not compete for the adomet (s-adenosyl-l-methionine, sam) binding site, blocks peptide substrate binding, hiv-1 rt polymerase inhibitor (ic50 = 5, 0 μm). | [in vivo]
AMI-1 (0.5 mg; intratumorally; daily; for 7 days) inhibits S180 viability in vivo[4].
?
AMI-1 (0.5 mg; intratumorally; daily; for 7 days) downregulates PRMT5 but does not regulate the expression of PRMT7 in a tumor xenograft model[4].
?
AMI-1 (0.5 mg; intratumorally; daily; for 7 days) decreases the levels of H4R3me2s and H3R8me2s in a tumor xenograft model[4].
| Animal Model: | 6-7 weeks old male Kunming mice (18-22 g), with S180 cells xenograft[4] | | Dosage: | 0.5 mg | | Administration: | Intratumorally, daily, for 7 days | | Result: | Decreased tumor weight. |
| [IC 50]
PRMT1 |
|
| Company Name: |
Spectrum Chemical Manufacturing Corp.
|
| Telephone: |
021-021-021-67601398-809-809-809 15221380277 |
| Website: |
www.spectrumchemical.com/oa_html/index.jsp?minisite=10020&respid=22372&language=us |
| Company Name: |
D&C Chemicals
|
| Telephone: |
+86-21-58447131 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList16963/0_EN.htm |
|